M P Piccardi - JoVE Visualize

Showing results (1-10 of 21) with videos related to

Pageof 3

Sort By:

Life Sciences|January 1, 1996

Heterogeneity of monoaminergic vesicular carriers: pharmacological evidence using MPP+ as a markerS Ruiu, M P Piccardi, A Bocchetta, et al.

Experimental Neurology|May 1, 1994

In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicityA Zuddas, F Fascetti, G U Corsini, et al.

Experientia|June 15, 1977

Changes in gastro-intestinal serotonin content associated with fasting and satiationG Biggio, M P Piccardi, M L Porceddu, et al.

Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1992

Localization of MPP+ binding sites in the brain of various mammalian speciesM Del Zompo, M P Piccardi, S Ruiu, et al.

Psychiatric Genetics|July 21, 1999

Maternal inheritance of manic depression in hemizygotes for the G6PD-Mediterranean mutation. Indirect evidence for Xq28 transmission in SardiniaA Bocchetta, M P Piccardi, V Martinelli, et al.

Biochemical Pharmacology|November 1, 1988

Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivoG U Corsini, A Bocchetta, A Zuddas, et al.

Journal of Neurochemistry|June 1, 1990

[3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion binding sites in mouse brain: pharmacological and biological characterizationM Del Zompo, S Ruiu, R Maggio, et al.

The Journal of Pharmacology and Experimental Therapeutics|August 1, 1986

A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidaseG U Corsini, S Pintus, A Bocchetta, et al.

Journal of Neurochemistry|September 1, 1985

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correspondence of its binding sites to monoamine oxidase in rat brain, and inhibition of dopamine oxidative deamination in vivo and in vitroA Bocchetta, M P Piccardi, M Del Zompo, et al.

Neuroscience|August 1, 1993

Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlatesA Albanese, R Granata, B Gregori, et al.

Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:

Pageof 3

Life Sciences|January 1, 1996

Heterogeneity of monoaminergic vesicular carriers: pharmacological evidence using MPP+ as a markerS Ruiu, M P Piccardi, A Bocchetta, et al.

Experimental Neurology|May 1, 1994

In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicityA Zuddas, F Fascetti, G U Corsini, et al.

Experientia|June 15, 1977

Changes in gastro-intestinal serotonin content associated with fasting and satiationG Biggio, M P Piccardi, M L Porceddu, et al.

Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1992

Localization of MPP+ binding sites in the brain of various mammalian speciesM Del Zompo, M P Piccardi, S Ruiu, et al.

Psychiatric Genetics|July 21, 1999

Maternal inheritance of manic depression in hemizygotes for the G6PD-Mediterranean mutation. Indirect evidence for Xq28 transmission in SardiniaA Bocchetta, M P Piccardi, V Martinelli, et al.

Biochemical Pharmacology|November 1, 1988

Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivoG U Corsini, A Bocchetta, A Zuddas, et al.

Journal of Neurochemistry|June 1, 1990

[3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion binding sites in mouse brain: pharmacological and biological characterizationM Del Zompo, S Ruiu, R Maggio, et al.

The Journal of Pharmacology and Experimental Therapeutics|August 1, 1986

A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidaseG U Corsini, S Pintus, A Bocchetta, et al.

Journal of Neurochemistry|September 1, 1985

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correspondence of its binding sites to monoamine oxidase in rat brain, and inhibition of dopamine oxidative deamination in vivo and in vitroA Bocchetta, M P Piccardi, M Del Zompo, et al.

Neuroscience|August 1, 1993

Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlatesA Albanese, R Granata, B Gregori, et al.

Pageof 3